Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 18.20
-0.25 (-1.36%)
Aug 13, 2026, 5:09 PM CET
Corline Biomedical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10.7 | 8.62 | 17.69 | 35.93 | 33.33 | 17.26 | |
Revenue Growth | -25.06% | -51.27% | -50.78% | 7.80% | 93.09% | 14.29% |
Cost of Revenue | 1.83 | 2.36 | 3.83 | 7.14 | 9.87 | 8.09 |
Gross Profit | 8.86 | 6.26 | 13.86 | 28.79 | 23.47 | 9.17 |
Selling, General & Admin | 22.34 | 20.35 | 26.93 | 28.74 | 20.89 | 15.95 |
Depreciation & Amortization Expenses | 0.08 | 0.08 | 0.1 | 0.1 | 0.06 | 0.03 |
Other Operating Expenses | 0.63 | 0.58 | 9.99 | 1.74 | 0.19 | 0.1 |
Total Operating Expenses | 23.05 | 21.01 | 37.02 | 30.58 | 21.14 | 16.08 |
Operating Income | -14.18 | -14.75 | -23.17 | -1.79 | 2.33 | -6.91 |
Interest Income | 0.04 | 0.04 | 0 | 0.01 | 0 | - |
Interest Expense | -0 | -0 | -0.03 | -0.03 | 0 | -0.01 |
Total Non-Operating Income (Expense) | 0.04 | 0.04 | -0.03 | -0.02 | 0 | -0.01 |
Pretax Income | -14.14 | -14.71 | -23.19 | -1.81 | 2.33 | -6.92 |
Net Income | -14.14 | -14.71 | -23.19 | -1.81 | 2.33 | -6.92 |
Net Income to Common | -14.14 | -14.71 | -23.19 | -1.81 | 2.33 | -6.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 25 | 25 | 22 | 21 | 21 | 20 |
Shares Outstanding (Diluted) | 25 | 25 | 22 | 21 | 22 | 20 |
Shares Change | 10.88% | 13.40% | 1.49% | -2.19% | 7.50% | 22.58% |
EPS (Basic) | -0.57 | -0.59 | -1.06 | -0.08 | 0.11 | -0.34 |
EPS (Diluted) | -0.57 | -0.59 | -1.06 | -0.08 | 0.11 | -0.34 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -17.91 | -17.74 | -8.64 | 0.75 | -6.61 | -4.98 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.72 | -0.72 | -0.40 | 0.04 | -0.30 | -0.24 |
Gross Margin | 82.85% | 72.62% | 78.34% | 80.13% | 70.40% | 53.12% |
Operating Margin | -132.60% | -171.16% | -130.98% | -4.98% | 6.99% | -40.02% |
Profit Margin | -132.24% | -170.72% | -131.14% | -5.03% | 6.99% | -40.10% |
FCF Margin | -167.46% | -205.78% | -48.85% | 2.10% | -19.82% | -28.82% |
EBITDA | -14.08 | -14.65 | -23.07 | -1.69 | 2.39 | -6.88 |
EBITDA Margin | -131.68% | -169.95% | -130.45% | -4.71% | 7.16% | -39.84% |
EBIT | -14.18 | -14.75 | -23.17 | -1.79 | 2.33 | -6.91 |
EBIT Margin | -132.60% | -171.16% | -130.98% | -4.98% | 6.99% | -40.02% |